Financials data is unavailable for this security.
View more
Year on year Oncimmune Holdings PLC had revenues fall -50.26% from 2.32m to 1.15m, though the company grew net income from a loss of 11.39m to a gain of 4.10m.
Gross margin | 63.34% |
---|---|
Net profit margin | -258.65% |
Operating margin | -95.14% |
Return on assets | -45.43% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in GBPView more
In 2023, Oncimmune Holdings PLC increased its cash reserves by 125.19%, or 1.78m. Cash Flow from Investing totalled 11.58m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 6.79m for operations while cash used for financing totalled 3.02m.
Cash flow per share | -0.0375 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0172 |
---|---|
Tangible book value per share | -0.0444 |
More ▼
Balance sheet in GBPView more
Current ratio | 1.14 |
---|---|
Quick ratio | 1.01 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.32 |
More ▼